Search results for: 'cancer development'

This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limitations of monoclonal antibodies have led to an increasing demand for novel formats. Companies are developing multispecific antibodies, such as bispecifics and trispecifics, and antibody fragments, such as Fab and ...

27 Oct 2021  |  Asia Pacific  |  Frost Radar

Frost Radar™ for Economic Development: Broader Asia, 2021

Australia, South Korea, and New Zealand Emerge as the Broader Asian Leaders

Infographics

×

Key Issues Addressed

The Frost Radar™ for Economic Development determines a region's future growth and development potential measured by its ability to enhance citizen satisfaction of quality of life. This report explores Broader Asia’s strengths and weaknesses through country-level assessments of growth and innovation initiatives and benchmarks each country on these t...

Although the telecoms landscape in APAC has changed a lot since the onset of the COVID-19 pandemic, data as a key driver of traffic and 5G monetization as the industry’s biggest bottleneck remain important trends impacting the industry. As 5G enterprise develops, enhanced mobile broadband (eMBB) is expected to continue to impact the mobile operator...

By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....

This research service evaluates the Western European cancer IVD market for Germany, the United Kingdom, Italy, Spain, France, Benelux and Scandinavia from 2010 to 2019. Beginning with an overview of the main market metrics and trends, the study identifies the key market drivers and restraints, evaluates ongoing competitive trends with detailed mark...

The global cancer survivorship care market has gained significance due to improvements in cancer treatment and the rising cancer survival rates. The availability of reimbursement policies in the United States favors the cancer survivorship care market in the country. Several health IT companies are considering the use of electronic health records (...

AI generative design technology is emerging as a transformative tool across various industries, including the automotive sector. The technology tool presents tremendous potential for innovation in automotive design by enabling OEMs to explore multiple design iterations swiftly and cost-effectively to produce more fuel-efficient, lightweight vehicle...

The growing global demand for sustainable and ethical food sources has led to significant advancements in alternative proteins. From plant-based proteins to cellular agriculture and novel fermentation techniques, researchers and industry pioneers are leveraging biotechnology, data analytics, and process optimization to enhance the efficiency and sc...